InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by ENGLE J MELVILLE, Chief Executive Officer. Insider active across 1 companies, notably Predictive Oncology Inc.. In total, 7 filings have been recorded. Total volume traded: €55k. The latest transaction was disclosed on 24 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations7 total
€55,264159,500 shares@ €0.3465100.0% of flow
Common Stock
SEC:0001415889-22-005573:0·
Ideal exit: 18 Feb 2023 (T+270)
020,428 shares0
Common Stock
SEC:0001179110-22-000327·
020,428 shares0
Common Stock
SEC:0001179110-22-000327:0·
04,512 shares0
Common Stock
SEC:0001179110-21-009200·
04,512 shares0
Common Stock
SEC:0001179110-21-009200:0·
09,924 shares0
Common Stock
SEC:0001179110-21-007393·
09,924 shares0
Common Stock
SEC:0001179110-21-007393:0·
7 of 7 declarations
About ENGLE J MELVILLE
J. Melville Engle is the CEO and Chairman at Predictive Oncology Inc. He is responsible for the strategic and operational direction of the company. His role includes managing resources and making key decisions to ensure growth and profitability. Through his leadership, he guides the company towards achieving its long-term objectives.
